GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $116,220,000 | +440.4% | 1,706,600 | +153.5% | 0.03% | +440.0% |
| Q2 2022 | $21,508,000 | -66.1% | 673,167 | -63.3% | 0.01% | -61.5% |
| Q1 2022 | $63,520,000 | +75.3% | 1,833,720 | +48.2% | 0.01% | +85.7% |
| Q4 2021 | $36,229,000 | +83.2% | 1,237,737 | +59.5% | 0.01% | +75.0% |
| Q3 2021 | $19,776,000 | -15.2% | 776,157 | +16.5% | 0.00% | -20.0% |
| Q2 2021 | $23,323,000 | +21.5% | 665,990 | +41.4% | 0.01% | 0.0% |
| Q1 2021 | $19,191,000 | -52.3% | 470,949 | -49.3% | 0.01% | -50.0% |
| Q4 2020 | $40,194,000 | +27.8% | 928,048 | +62.7% | 0.01% | +11.1% |
| Q3 2020 | $31,448,000 | -18.8% | 570,318 | -7.1% | 0.01% | -25.0% |
| Q2 2020 | $38,740,000 | -5.2% | 613,654 | -23.3% | 0.01% | -14.3% |
| Q1 2020 | $40,859,000 | -9.4% | 799,757 | +41.0% | 0.01% | +27.3% |
| Q4 2019 | $45,080,000 | +122.0% | 567,112 | +35.5% | 0.01% | +83.3% |
| Q3 2019 | $20,310,000 | -34.4% | 418,586 | -28.8% | 0.01% | -25.0% |
| Q2 2019 | $30,945,000 | +13.5% | 588,312 | +14.2% | 0.01% | 0.0% |
| Q1 2019 | $27,273,000 | +54.9% | 515,276 | +20.1% | 0.01% | +33.3% |
| Q4 2018 | $17,606,000 | +9.1% | 428,902 | +1.0% | 0.01% | +50.0% |
| Q3 2018 | $16,138,000 | -23.0% | 424,678 | -8.5% | 0.00% | -20.0% |
| Q2 2018 | $20,969,000 | -2.0% | 463,925 | +4.7% | 0.01% | 0.0% |
| Q1 2018 | $21,401,000 | +81.7% | 443,072 | +48.0% | 0.01% | +66.7% |
| Q4 2017 | $11,779,000 | +25.8% | 299,335 | -0.8% | 0.00% | +50.0% |
| Q3 2017 | $9,365,000 | +7.8% | 301,617 | -5.0% | 0.00% | 0.0% |
| Q2 2017 | $8,686,000 | +131.4% | 317,571 | +211.7% | 0.00% | +100.0% |
| Q1 2017 | $3,754,000 | +555.1% | 101,881 | +157.0% | 0.00% | – |
| Q4 2016 | $573,000 | -49.6% | 39,650 | -42.1% | 0.00% | – |
| Q2 2016 | $1,137,000 | -88.6% | 68,529 | -89.1% | 0.00% | -100.0% |
| Q1 2016 | $9,974,000 | +1148.3% | 628,859 | +2443.9% | 0.00% | – |
| Q4 2015 | $799,000 | +215.8% | 24,720 | +312.1% | 0.00% | – |
| Q3 2015 | $253,000 | – | 5,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |